Convergence: How Five Trends Will Reshape the Social Sector

This report highlights five key trends and how their coming together will shape the social sector of the future. Based on extensive review of existing research and in-depth interviews with thought leaders and nonprofit leaders and activists, it explores the trends (Demographic Shifts; Technological Advances; Networks Enabling Work to be Organized in New Ways; Rising Interest in Civic Engagement and Volunteerism; and Blurring of Sector Boundaries) and looks at the ways nonprofits can successfully navigate the changes. The monograph is by La Piana Consulting, a national firm dedicated to strengthening nonprofits and foundations

Strategic Restructuring for California Community Clinics: Self-Assessment Workbook

Offers a tool for assessing clinics' capacities, strengths and weaknesses, and the needs and assets of potential partner organizations; compatibility; and restructuring strategies that maximize innovation, flexibility, and impact

Identifying New Treatments For Memory Disorders: From Mice To Men

The population of older Americans will expand greatly in the next 20 years and, as a consequence, disorders of aging, such as Alzheimer’s disease, will become more prevalent. Drug treatments for Alzheimer’s disease currently exist, however they are either ineffective for some people or cause significant side effects. These drugs were developed to correct imbalances in brain chemistry, which may or may not exist early in the disease. However, a brain abnormality that clearly appears early in the course of Alzheimer’s disease is neuronal injury and/or loss in the hippocampus and related medial temporal lobe structures of the brain. The purpose of our research has been to experimentally produce a similar condition of neuronal loss in laboratory animals and to use these animals to test the efficacy of potential new treatments for Alzheimer’s disease. Animals (rats and mice) with neuronal loss in the hippocampus exhibit changes in activity that may be relevant to the agitation observed in Alzheimer’s disease. Moreover, such animals demonstrate profound memory deficits, especially in the area of spatial memory. Our research to date has shown that drugs that are currently used in the treatment of Alzheimer’s disease are ineffective in improving memory in animals with hippocampal neuronal loss. However, some antipsychotic drugs that are prescribed for agitation in Alzheimer’s disease also seem to slightly improve memory in animals with hippocampal neuronal loss. This research should enhance our understanding of the biological basic of memory and offer new insights into improving treatment for memory disorders